Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CytoMed Therapeutics Limited - Ordinary Shares (NQ: GDTC ) 2.124 +0.034 (+1.63%) Streaming Delayed Price Updated: 3:09 PM EDT, Jul 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about CytoMed Therapeutics Limited - Ordinary Shares Navigating the Challenges Facing an Aging Global Population: How CytoMed Seeks to Help Boost Cartilage Regeneration March 20, 2024 The global population is rapidly aging. According to the World Population Prospects 2022 published by the United Nations, there were Via Spotlight Growth CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration March 20, 2024 Via ACCESSWIRE CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies March 18, 2024 From CYTOMED THERAPEUTICS LIMITED Via GlobeNewswire CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair March 04, 2024 CytoMed diversifies into regenerative medicine From CYTOMED THERAPEUTICS LIMITED Via GlobeNewswire Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology January 29, 2024 The Company now has exclusive rights to a Malaysia, US and China patent From CYTOMED THERAPEUTICS LIMITED Via GlobeNewswire Singapore’s Journey to Becoming a Biotech Powerhouse October 24, 2023 Singapore's Biotech Vision: From 2000 Onwards In 2000, Singapore embarked on an ambitious mission to establish itself as a leading Via Spotlight Growth Topics Economy Exposures Economy CytoMed Expands Research Collaboration into China After Entering Into MOU August 29, 2023 Via ACCESSWIRE Singapore’s Leap into the Future of Cell and Gene Therapies August 29, 2023 Singapore is making remarkable progress in the realm of cell and gene therapy (CGT), as evidenced by the inauguration of Via Spotlight Growth The Dawn of a New Era in Immunotherapy for Cancers: Understanding CytoMed Therapeutics’ (NASDAQ: GDTC) iPSC-Derived Gamma Delta NKT Cell Technology July 27, 2023 CytoMed Therapeutics, a NASDAQ-listed company (Stock Symbol: GDTC), is at the forefront of a revolution in cellular therapy for cancers. Via Spotlight Growth CytoMed Therapeutics Collaborates With Cancer Treatment Center to Advance Its Unique CAR-T Technology June 28, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire CytoMed (NASDAQ: GDTC): Revolutionizing Cancer Treatment with Unique CAR-T Cell Technology June 28, 2023 Despite the substantial advances in medical technology, cancer remains a formidable foe with an alarming annual growth rate. According to Via Spotlight Growth Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.